Benitec Biopharma (BNTC) Cost of Revenue: 2019-2024
Historic Cost of Revenue for Benitec Biopharma (BNTC) over the last 1 years, with Mar 2024 value amounting to $3,000.
- Benitec Biopharma's Cost of Revenue was N/A to $3,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $119,000, marking a year-over-year change of. This contributed to the annual value of $108,000 for FY2024, which is N/A change from last year.
- Latest data reveals that Benitec Biopharma reported Cost of Revenue of $3,000 as of Q1 2024, which was up 200.00% from $1,000 recorded in Q4 2023.
- Over the past 5 years, Benitec Biopharma's Cost of Revenue peaked at $134,000 during Q3 2020, and registered a low of -$48,000 during Q2 2020.
- In the last 3 years, Benitec Biopharma's Cost of Revenue had a median value of $6,000 in 2022 and averaged $29,750.
- Its Cost of Revenue has fluctuated over the past 5 years, first crashed by 93.79% in 2020, then skyrocketed by 800.00% in 2022.
- Quarterly analysis of 5 years shows Benitec Biopharma's Cost of Revenue stood at $19,000 in 2020, then surged by 102.08% to $1,000 in 2021, then surged by 800.00% to $9,000 in 2022, then reached $1,000 in 2023, then reached $3,000 in 2024.
- Its Cost of Revenue stands at $3,000 for Q1 2024, versus $1,000 for Q4 2023 and $106,000 for Q3 2023.